Studies on the effects of heparin products on pregnancy-associated plasma protein A.

[1]  P. Porela,et al.  Free vs total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome. , 2010, Clinical chemistry.

[2]  A. Jaffe,et al.  PAPP-A as a marker of increased long-term risk in patients with chest pain. , 2009, Clinical biochemistry.

[3]  P. Porela,et al.  Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A. , 2009, Clinical chemistry.

[4]  P. Clemmensen,et al.  Release patterns of pregnancy‐associated plasma protein A in patients with acute coronary syndromes assessed by an optimized monoclonal antibody assay , 2009, Scandinavian journal of clinical and laboratory investigation.

[5]  P. Clemmensen,et al.  Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction. , 2008, The American journal of cardiology.

[6]  Le-Xin Wang,et al.  Levels of pregnancy-associated plasma protein A in patients with coronary artery disease. , 2008, Clinical and investigative medicine. Medecine clinique et experimentale.

[7]  C. Conover,et al.  Genetic Deletion of Pregnancy-Associated Plasma Protein-A Is Associated With Resistance to Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice Challenged With a High-Fat Diet , 2007, Circulation research.

[8]  K. Iversen,et al.  Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy-associated plasma protein (PAPP-A) in acute coronary syndrome. , 2007, Clinical biochemistry.

[9]  S. Thiel,et al.  Cell Surface Detachment of Pregnancy-associated Plasma Protein-A Requires the Formation of Intermolecular Proteinase-Inhibitor Disulfide Bonds and Glycosaminoglycan Covalently Bound to the Inhibitor* , 2007, Journal of Biological Chemistry.

[10]  Kim Pettersson,et al.  Immunofluorometric point-of-care assays for the detection of acute coronary syndrome-related noncomplexed pregnancy-associated plasma protein A. , 2006, Clinical chemistry.

[11]  R. Schwartz,et al.  Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. , 2006, Journal of the American College of Cardiology.

[12]  K. Pettersson,et al.  Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. , 2006, Clinical chemistry.

[13]  Kim Pettersson,et al.  Pregnancy‐associated plasma protein A: A biomarker in acute ST‐elevation myocardial infarction (STEMI) , 2006, Annals of medicine.

[14]  C. Heeschen,et al.  Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. , 2005, Journal of the American College of Cardiology.

[15]  L. Sokoll,et al.  Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[16]  P. Porela,et al.  Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I Elevation , 2003, Circulation.

[17]  L. Giudice,et al.  Cell Surface Targeting of Pregnancy-associated Plasma Protein A Proteolytic Activity , 2002, The Journal of Biological Chemistry.

[18]  Philippe Monget,et al.  Pregnancy-Associated Plasma Protein-A Is Involved in Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) Proteolytic Degradation in Bovine and Porcine Preovulatory Follicles: Identification of Cleavage Site and Characterization of IGFBP-2 Degradation1 , 2002, Biology of reproduction.

[19]  J. Khosravi,et al.  Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease. , 2002, Clinical Biochemistry.

[20]  K. Bailey,et al.  Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. , 2001, The New England journal of medicine.

[21]  L. Giudice,et al.  Pregnancy‐associated plasma protein‐A (PAPP‐A) cleaves insulin‐like growth factor binding protein (IGFBP)‐5 independent of IGF: implications for the mechanism of IGFBP‐4 proteolysis by PAPP‐A , 2001, FEBS letters.

[22]  C. Conover,et al.  Expression of Recombinant Human Pregnancy-associated Plasma Protein-A and Identification of the Proform of Eosinophil Major Basic Protein as Its Physiological Inhibitor* , 2000, The Journal of Biological Chemistry.

[23]  J R Yates,et al.  The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Oxvig,et al.  Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. , 1994, Biochimica et biophysica acta.

[25]  J. Grudzinskas,et al.  Pregnancy associated plasma protein-A: interaction with heparin in crossed affinity immunoelectrophoresis. , 1981, Australian and New Zealand journal of medicine.

[26]  W. Spellacy,et al.  Characterization of four human pregnancy-associated plasma proteins. , 1974, American journal of obstetrics and gynecology.

[27]  C. Terkelsen,et al.  Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration. , 2009, The American journal of cardiology.

[28]  T. Henry,et al.  Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. , 2008, The American journal of cardiology.

[29]  Kim Pettersson,et al.  Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. , 2005, Clinical chemistry.